|
MRI News Service:
'Gadobutrol' |
|
| Result: Searchterm 'Gadobutrol' found in 12 news | | Result Pages | | More Results:  Database (2) |
|
|
 |
 | | | ''GE HealthCare has expanded its magnetic resonance imaging (MRI) contrast agent portfolio with the launch of Pixxoscan (gadobutrol). Designed to enable the visualisation of abnormal structures ...' | | Friday, 28 April 2023 by www.medicaldevice-network.com |
|
|
|
| | | ''Guerbet, today announced positive results from two Phase III clinical studies comparing the diagnostic efficacy and safety of Gadopiclenol to Gadobutrol in a wide range of indications, covering ...' | | | Wednesday, 24 March 2021 by www.guerbet.com | |
|
|
|
| | | ''Approval based on data demonstrating the pharmacokinetic and safety profiles of Gadovist at standard dose (0.1 mmol/kg) were similar to adults and children 2 years of age and older / Diagnostic use in approved indications has been expanded to include use ...' | | | Tuesday, 14 July 2015 by pipelinereview.com | |
|
|
|
| | | ''Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use with magnetic resonance imaging (MRI) in pediatric patients less than 2 years of age, including term neonates, to ...' | | | Monday, 5 January 2015 by www.prnewswire.com | |
|
|
|
| | | ''Data from a Bayer study in children (infants) less than 2 years of age will be presented today at the 2014 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting.1 The primary endpoint of the study was the evaluation of the ...' | | | Wednesday, 3 December 2014 by www.prnewswire.com | |
|
|
|
| | | ''Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Gadavist® (gadobutrol) injection for intravenous use with MRI of the breast to assess the presence and extent of malignant breast ...' | | | Thursday, 12 June 2014 by www.prnewswire.com | |
|
|
|
| | | ''Bayer HealthCare Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved Bayer's gadobutrol injection Gadavist™ (gadobutrol), a 1.0 molar macrocyclic gadolinium-based contrast agent (GBCA) for intravenous use in ...' | | | Tuesday, 15 March 2011 by viva.vita.bayerhealthcare.de | |
|
|
|
| | | ''Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) voted unanimously that clinical trial and postmarketing data for gadobutrol ...' | | | Friday, 21 January 2011 by www.biospace.com | |
|
|
|
| | | ''The FDA's panel of outside neurology experts will meet Friday to discuss risks for a serious skin disorder presented by a new, contrast agent for MRI scans of the central nervous system. The product -- gadobutrol, made by Bayer -- is one of a class ...' | | | Thursday, 20 January 2011 by www.medpagetoday.com | |
|
|
|
| | | ''Bayer Schering Pharma AG, Berlin, Germany, announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the U.S. for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance ...' | | | Friday, 6 August 2010 by www.medicalnewstoday.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
It was the experience of mystery -- even if mixed with fear --
that engendered religion.
- Albert Einstein |
|
|
News
top
